BPC157 + TB Frag Blend

Description

BPC-157 + TB Frag Blend is a co-formulated research reagent for laboratories working on tissue-repair, cell-migration and recovery models. It puts two of the most frequently requested research peptides in Canada into a single lyophilized vial — 10mg of BPC-157 alongside 10mg of the TB-500 (thymosin β4) active fragment — so a single reconstitution produces a working stock containing both compounds at a known, fixed ratio.

Overview

BPC-157 is a synthetic pentadecapeptide sequence derived from a protein found in gastric juice, and is one of the most widely cited compounds in in-vitro repair and angiogenesis literature. TB-500 is the synthetic active fragment of thymosin β4, the actin-binding protein studied for its role in cell migration and cytoskeletal dynamics. The two are commonly examined together because their described mechanisms are distinct rather than overlapping, which makes a fixed-ratio blend useful when a protocol calls for both. The product ships as a sterile-filled, lyophilized white powder in a sealed vial, ready for reconstitution in a suitable research solvent such as bacteriostatic or sterile water. Choose a single vial for a discrete experiment, or a box of ten where a study runs across multiple arms or time points.

What it is known for

Buyers know this blend for two things: the convenience of a 1:1 10mg+10mg fill that removes the arithmetic and pipetting error of combining two separately reconstituted peptides, and the independent analytical paperwork behind it. Every batch is tested by Janoshik, a third-party laboratory, for purity by HPLC and identity by mass spectrometry, with a certificate of analysis matched to the batch you receive — not a generic document reused across production runs. That combination of a defined specification and verifiable, batch-specific data is why it is chosen over unspecified blends of unknown ratio.

Key features

• Fixed 10mg + 10mg fill in one vial — Both peptides enter solution at a known ratio in a single step, so your stock concentration is defined by one reconstitution volume rather than two — fewer transfers, fewer chances to introduce error.
• Lyophilized powder format — The freeze-dried cake is far more stable than a liquid, so the material tolerates shipping and cold storage and you control the solvent and final concentration to suit your protocol.
• Independent HPLC purity testing — Purity is quantified by a lab with no commercial interest in the result, so unrelated peaks and process impurities that could confound an assay are identified before the vial reaches your bench.
• Mass spectrometry identity confirmation — Confirms the material in the vial is the peptide it claims to be at the expected mass — the check that separates a specified reagent from an unverified powder.
• Batch-matched certificate of analysis — The documentation corresponds to your specific production lot, which is what a supervisor, grant record or methods section actually needs.
• TB-500 supplied as the active fragment — The fragment is the form used in the published research most laboratories are reading, so results can be compared against the existing literature rather than an unrelated analogue.
• Cold storage and discreet tracked shipping within Canada — Domestic dispatch keeps transit short and avoids customs delays and border holds on temperature-sensitive material, and tracking lets you plan the reconstitution around a known arrival.
• Box-of-ten option — Lets a multi-arm or repeated-timepoint study run on a single production lot, so batch variation is removed as a variable across the whole experiment.

Benefits

• One vial, one reconstitution, a defined ratio of both peptides — less handling and less opportunity for dosing error in the preparation step.
• Analytical data you can cite, from an outside laboratory, rather than a supplier’s own assurance.
• Confidence that an unexpected result reflects your model and not an unidentified impurity in the reagent.
• Consistency across a study when you order a box from one batch.
• Reliable Canadian dispatch, so cold-chain material spends less time in transit.

Specifications

Typical applications

• In-vitro tissue-repair and wound-model research
• Cell migration and cytoskeletal studies involving thymosin β4 biology
• Angiogenesis and endothelial cell assays
• Comparative work examining single peptides against a combined preparation
• Method development and analytical reference work in a laboratory setting

Important information

• Research use only. This product is not a drug, supplement, food or cosmetic, is not intended to diagnose, treat, cure or prevent any disease, and is not for human or veterinary use, ingestion or administration.
• Keep the sealed vial cold until you are ready to use it, and return reconstituted material to cold storage promptly.
• Reconstitute in a suitable research solvent such as bacteriostatic or sterile water; direct the stream against the vial wall rather than onto the lyophilized cake, and swirl gently rather than shaking.
• Because both peptides are present in one vial, they cannot be dosed independently — if your protocol requires separate concentrations, use the individual compounds instead.
• Request the certificate of analysis for the batch you receive and keep it with your records; confirm the batch number on the vial matches the document.
• Handle with standard laboratory practice: appropriate PPE, a clean work area, and disposal in line with your institution’s protocols.

Common questions

What exactly is in the vial?

A lyophilized blend of 10mg BPC-157 and 10mg of the TB-500 (thymosin β4) active fragment — 20mg of peptide in total, in a 1:1 ratio.

Why buy a blend rather than the two peptides separately?

Convenience and consistency. A single reconstitution gives you both compounds at a fixed, known ratio, which removes a combining step and the error that comes with it. Buy them separately if your protocol needs to vary the two concentrations independently.

How is quality verified?

Every batch goes to Janoshik, an independent analytical laboratory, for HPLC purity and mass spectrometry identity testing. A certificate of analysis matched to your batch is available on request.

How should it be reconstituted and stored?

The sealed lyophilized vial should be kept cold. Reconstitute in a suitable research solvent for your protocol, adding it slowly down the side of the vial and swirling rather than shaking, then keep the solution refrigerated. Final concentration is determined by the volume you add.

Who can order this?

Qualified research buyers — laboratories, universities, biotech companies and researchers — for in-vitro laboratory work only.

Where does it ship from?

Within Canada, cold-stored and discreetly packaged, with nationwide tracking. Domestic dispatch keeps transit short for temperature-sensitive material.

In summary

A single-vial preparation of BPC-157 and the TB-500 active fragment at 10mg each, freeze-dried, independently tested by HPLC and mass spectrometry, and backed by a certificate of analysis tied to your batch. If your work calls for both peptides together and you need reagent documentation that stands up to scrutiny, this is the straightforward way to get it.